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Background: Transcription activator-like effectors (TALEs) are a class of naturally occurring transcription effectors
that recognize specific DNA sequences and modulate gene expression. The modularity of TALEs DNA binding
domain enables sequence-specific perturbation and offers broad applications in genetic and epigenetic studies.
Although the efficient construction of TALEs has been established, robust functional tools to assess their functions
remain lacking.
Results: We established a dual reporter system that was specifically designed for real-time monitoring and
quantifying gene expression mediated by TALEs. We validated both sensitivity and specificity of this dual-reporter
system in mammalian cells, and demonstrated that this dual reporter system is robust and potentially amenable to
high throughput (HTP) applications.
Conclusion: We have designed, constructed and validated a novel dual reporter system for assessing TALE
mediated gene regulations. This system offers a robust and easy-to- use tool for real-time monitoring and
quantifying gene expression in mammalian cells.
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Zinc-finger nucleases (ZFNs) and meganucleases have
been well-established as tools to edit specific sites in
complex genomes [1,2]. However, the DNA-binding do-
main of zinc-finger nucleases are challenging to design
and require experimental optimization, and the target
sequences of meganucleases are limited. Transciption
activator-like effector (TALE) technology has recently
emerged as an alternative robust and efficient genome
editing tool [3,4]. Natural TALEs are transcription fac-
tors used by plant-pathogenic bacteria in the genus
Xanthomonas. The native function of TALEs is to
modulate host gene expression by binding to specific
sequences in host gene promoters and activate transcrip-
tion [5,6]. The DNA binding domain of TALEs consist
of a central domain of 33–35 amino acid repeats* Correspondence: blu@systembio.com
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peat of 20 amino acids. The tandem repeats are nearly
identical, except for two variable amino acids in position
12 and 13, referred to as “repeat-variable di-residue”
(RVD), with the four most common RVDs each specify-
ing binding of one of the four DNA bases [7,8]. The
modular nature of the TALE DNA-binding domain and
the straightforward sequence relationships enables effi-
cient customization of TAL effector repeat domains. The
simplicity of TALE design and construction to target
nearly any DNA sequence within the genome has been
an important advantage of the technology [9,10].
TALEs with customized DNA-binding domains can be
fused to the catalytic domain of the FokI nuclease to cre-
ate targeted DNA double-strand breaks in vivo for gen-
ome editing [11-15]. TAL effector nucleases (TALENs)
function in pairs, as FokI cleaves DNA upon dimerization.
Double-strand breaks will be repaired in most cells by
non-homologous end joining, which frequently results in
small deletions or insertions, thus leading to potentialntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Figure 1 Design and Construction of the dual reporters and their functional characterization. (a) Schematic representation of core
features of the dual reporter system, depicting the two reporter genes GFP and luciferase separated by T2A (self-cleavage peptide), under the
control of a minimal CMV promoter (mCMV). The multiple cloning sites (MCS) were incorporated to facilitate the insertion of TALE binding
sequences. (b) Schematic representation of the promoterless dual reporter system serving as a negative control. (c) Schematic representation of
the dual reporters under the control of a full CMV promoter serving as a positive control. HEK293 cells transfected with the negative control
(promoterless) displayed weak GFP expression (d), while the minimal CMV promoter resulted in low to moderate GFP expression (e); the positive
control (full CMV promoter) showed strong GPP expression (f). (g) Luciferase activities of each reporter, displayed in arbitrary units. Error bars
indicate SD; n = 3. (h) Flow chart showing how to use the dual reporter to monitor TALE action. Specific TALE reporters can be constructed by
inserting the TALE binding sequence (TBS) into the MCS. These customized reporters can then be used to trace TALE action in mammalian cells
by co-transfection with the corresponding TALE.
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in presence of a donor sequence can be harnessed for
gene insertion or replacement [4]. Recently, engineered
TALENs have been shown as a robust gene editing tool in
a number of species [4,16-20]. Similarly, sequence-specific
TALEs for modulating eukaryotic gene activation or re-
pression have also been reported [21,22]. With the avail-
ability of efficient assembly of TALEs for use in
mammalian cells, attention starts to shift to develop func-
tional monitoring tools. Although a single reporter system
using either fluorescent protein or luciferase has been
reported, neither system is commercially available or
amenable to HTP applications [23]. Here we demon-
strated the design, construction and validation of a novel
dual-reporter system for the real-time monitoring and
quantification of gene expression mediated by TALEs.
With the simplicity and robustness of this dual reporter
system, this novel tool offers a solution for functional as-
sessment of gene regulation mediated by TALEs with high
sensitivity and specificity.
Results and Discussion
Features of the dual reporter for TALEs
The dual reporter for TALEs was designed to make use
of the unique property of two reporters: green fluores-
cent protein (GFP) and firefly luciferase. While GFP by
itself offers a visual, real-time monitoring of gene activa-
tion, the quantification is time-consuming and requires
the use of expensive analysis machine such as flow cyto-
metry. To overcome this limitation, we designed a dual
reporter, which combines GFP with a quantifiable luci-
ferase (Figure 1a). Because luciferase reporter can pro-
vide a cost-effective way of quantification, together this
dual reporter system offers a powerful tool superior to
any single reporter system.
To monitor TALE-induced gene expression, a minimal
promoter is required to turn on the transcription of
down-stream reporters. We chose the minimal CMV
promoter (mCMV), which has been demonstrated to
function in various mammalian cells. To minimize the
non-specific influence of transcription, cares were taken
to mutate the potential transcription binding sites within
the backbone. In addition, a transcription stoppersequence was placed before the TALE binding sites, dir-
ectly upstream of a multiple cloning site (MCS)
(Figure 1a). To evaluate the background activities, a pro-
moterless reporter was constructed as negative control
(Figure 1b). Similarly, a full-length CMV promoter re-
porter was constructed as positive control to validate ex-
perimental parameters such as transfection conditions
and efficiencies (Figure 1c).
We next determined the function of these reporters in
mammalian cells. As expected, transfection of human
embryonic kidney cells (HEK293) with promoterless re-
porter showed no GFP-positive cells and was used to es-
tablish background-level luciferase activity (Figure 1d).
Under the same experimental conditions, a few GFP-
positive cells were detected for the dual reporter with
mCMV promoter (Figure 1e). In contrast, more than
85% cells showed GFP positive for the positive control
reporter (Figure 1f ). A low to moderate level (695-fold
increase vs. promoterless control) of luciferase activity
was detected for the minimal promoter, while a very
robust level (>150000-fold increase vs. promoterless
controls) was observed for the positive control reporter
(Figure 1g). These results demonstrated the desired
functions of our dual reporter system. Two key features
are worthy to note: first, the dual reporter has very low
background noise and potentially very high signal levels
in mammalian cells (HEK293 cells, Figure 1). Secondly,
the low to moderate basal activity of the dual reporter
offers a potential capability to monitor both an increase
or decrease in gene expression (unpublished data).
To facilitate monitoring the transcription activity of
TALE-TF (transcription factor), multiple cloning sites
were readily placed at the immediate upstream of
the mCMV. In this way, TALE-TF binding sites will
be in optimal position for transcriptional activation
(within 200 bp upstream of transcription start sites). Of
note ~3-5 binding sites are normally engineered into re-
porter construct to increase the sensitivity of reporters
(Figure 1h).
Specificity of dual reporters for TALE-TF
We next investigated the specificity of dual reporters in
the context of monitoring TALE-TF. The programmable
Figure 2 (See legend on next page.)
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Figure 2 Specific activation of dual reporters by TALEs. (a) Upper two panels: TALE-TF designed to activate the Sox2 gene were placed
under the control of either CMV or EF1-a promoter. The target sites were selected from the 200-bp proximal promoter region of human Sox2 as
indicated by Sox2-TALE binding sites (SBS). Lower two panels: the corresponding customized dual reporter was constructed by inserting 3xSBS.
A control reporter harboring 3xUBS was set as a negative control. (b) Upper panel: Images of TALE-induced GFP reporter expression in
trasnfected HEK293 cells. Lower panel: Levels of luciferase activities in transfected HEK293 cells, as determined by quantitative luciferase assay, in
comparison to mock controls. Mock control cells received the same amount of plasmid DNA, but the Sox2 TALE-TF plasmid was replaced by
empty vector. Data are expressed as mean± SD, n = 3.
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of any target DNA-binding site. We chose the Sox2-
TALE-TF, as this TALE has been previously demon-
strated to be able to activate both the endogenous Sox2
gene and a reporter [24]. As shown in Figure 2, we con-
structed two Sox2-TALE-TF expression vectors: one
with a CMV promoter to achieve high expression and
the other with an EF1a promoter to achieve moderate
expression (Figure 2a). The Sox2-TALE-TF binding
sequences were deduced from the Sox2 effector binding
domain, and used for construction of its dual reporterFigure 3 The robustness of dual reporters. (a and b, upper panels): Im
Low-range of Sox2-TALE-TF input, images taken at 20x magnification (b) H
magnification. (a and b, lower panels): Levels of luciferase activities expre
Sox2-TALE-TF input. The fold induction of the reporter was calculated as re
(dual reporter plus empty TALE-TF vector).(Figure 2a). Specifically, a double-stranded DNA frag-
ment containing three binding sites were synthesized,
PCR-amplified and subsequently cloned into the MCS.
To avoid potential interference of DNA binding to the
tandem binding sites, each target sites were inserted
with an arbitrary spacer (5-bp). A similar reporter with
unrelated repeat sequences was also built as negative
control (Figure 2a).
To evaluate the specificity of the above reporters, a
co-transfection experiment was conducted in HEK293
cells. As shown in Figure 2b (the upper 2nd panel), whenages of TALE-induced GFP reporter expression in HEK293 cells. (a)
igh-dose range of Sox2-TALE-TF input, images taken at 10x
ssed as mean± SD, n = 3 at low-dose (a) and high-dose (b) range of
lative activity of each dosage compared to the corresponding control
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the Sox2-TALE-TF, >85% HEK293 cells were GFP posi-
tive. In contrast, barely any GFP positive cells showed
up in the mock transfection controls using empty vector
DNA lacking the Sox2-TALE-TF (Figure 2b, the upper
1st panel). Correspondingly, a 221-fold increase in luci-
ferase activity was observed in co-transfected cells, while
the mock control displayed only low activity. Because
the only difference of these two constructs are the
TALE-binding sites, these data strongly support that the
dual reporter system is both a sensitive and a specific
method to validate TALE activity.
To further confirm that this dual reporter configur-
ation is useful in validating TALEs function, a new set of
dual reporters were built with a different plasmid back-
bone, namely the minicircle plasmid DNA. To demon-
strate the specificity of the dual reporter in these new
vector backbones, the same co-transfection experiments
were conducted. As shown in Figure 2c, Sox2-TALE-TF
specifically activated reporter genes to a similar extend,
with a drastic increase in the numbers of GFP-positive
cells, and a 245-fold increase in luciferase activity. These
results further validated that the dual reporter is useful
for specifically monitoring gene activation mediated by
TALEs, and indicate that the core configuration of the
dual reporter can be applied to a broad range of plasmid
backbones.
Sensitivity of the dual reporter system
The above findings indicate that the dual reporters are
specific and robust (> 200 fold increase), as demon-
strated by two sets of vectors. To further examine theFigure 4 Real-time monitoring and quantification of TALE in living ce
were taken at indicated time-points after co-transfection of Sox2-TALE-TF a
relative activity at each time-point compared to its corresponding control (
are expressed as mean± SD, n = 3.sensitivity of this dual reporter, we performed dose–
response experiments. As shown in Figure 3a, as low as
1 ng effector DNA induced GFP positive cells (white
arrows), and the number of GFP positive cells increased
in parallel with the increasing dosages of effector DNA
to a maximum of 2.5 ug tested. Consistent with GFP
results, there was also a dose-dependent increase in luci-
ferase activity. Specifically, the lowest dose of 1 ng ef-
fector DNA input resulted in a significant 15-fold
increase compared to the empty-vector DNA control,
while the highest dose of 2.5 ug resulted in a marked
9847-fold increase in luciferase activities. These data
strongly support the notion that these dual reporters
may serve as a robust functional validation system for
customized TALE-TFs with both high sensitivity and
specificity.
Monitoring TALE-TF action in real-time
One important advantage for the use of dual reporters is
that GFP allows real-time monitoring in living cells,
while luciferase enables easy quantification. To test the
ability of GFP as a visual tool to monitor TALE-
mediated gene regulation, we conducted time-course
studies using our dual reporters. As shown in Figure 4a,
as early as 3 hours after transfection, a few weak GFP-
positive cells were observed in HEKs co-expression of
Sox2-TALE-TF with dual reporters. The number of
GFP-positive cells and the intensity increased with time,
reached a peak at 24 hours, and then attenuated at
30 hours. Under the same experimental condition, both
the number of GFP positive cells and the intensity are
much lower in the empty-vector DNA (no TALE-TF)lls. Images of TALE-induced GFP reporter expression in HEK293 cells
nd its dual reporter. (b) Fold induction of luciferase was calculated as
dual reporter plus empty TALE-TF vector). Levels of luciferase activities
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delay. In agreement with GPF results, there is a
corresponding increase in luciferase activity in a time-
dependent manner (Figure 4b) These results confirm the
specific effects of TALE-TF, as well as the feasibility of
real-time monitoring of TALE-TF action by our dual re-
porter system. Together, these observations provide a
strong correlation between the visual GFP assessment
and luciferase quantification.
Conclusion
We have designed and built a dual reporter system for
the functional evaluation of TALE-TF. In addition, we
have validated specificity and sensitivity of this robust
reporter system. Since this dual reporter system allows
real-time monitoring and cost-effective quantification, it
will add a great value to the community using TALE-TF
models to study gene regulation in mammalian cells.
Methods
Construction of dual reporters and TALEs
The dual reporter system is configured from the 5’ to 3’
as follows: a transcription stopper sequence, MCS,
mCMV, GFP-T2A-Luciferase, followed by a Poly A sig-
nal (core sequence). The components of the core se-
quence were PCR amplified and fused together using
gene fusion technology (SBI, Mountain View, CA). The
above dual reporter sequences were subsequently cloned
into either a regular plasmid with an ampicillin selection
marker or a minicircle plasmid with a kanamycin selec-
tion marker (SBI, Mountain View). In addition, reporters
without mCMV or with a full-length CMV promoter
sequences were similarly constructed to serve as nega-
tive or positive controls. For TALE transcription activa-
tors, we placed the Sox2 gene activator into a lentiviral
vector under the control of CMV. This Sox2-TALE-TF
is designed to target a 14-mer sequence site located at
the proximal promoter of the human Sox2 gene. Three
binding repeats of the Sox2 14-mer or three repeats of
unrelated 14-mers as negative control were subcloned
into the MCS of the above dual reporters.
Cell culture
HEK cells were maintained in high glucose Dulbecco’s
Minmal Essential Medium (DMEM) supplemented with
10% FBS, 2 mM GlutaMax (Life Technologies), penicil-
lin/streptomycin. Cells were incubated at 37°C and 5%
CO2. At ~80% confluence, cells were washed with PBS
and passaged with 0.25% trypsin-EDTA for dissociation.
Transfection and reporter gene assay
For transfections, HEK cells were seeded on 6-well
plates at a density of 1 x 105/well, and a total of 1 ug dual
reporter and 2 ug effector DNA (Sox2-TALE-TF orempty vector DNA mock control) with polymer-based
transfection reagent (SBI, Mountain view, CA) were
added to the media following manufacturer’s instruction.
If not stated otherwise, cells were harvested 18 hours
after transfection for measuring luciferase activity, using
a Luciferase assay kit according to manufacturer’s
instructions (Promega, Madison, WI).
Data collection and presentation
For real-time monitoring, cultured cells were monitored
at regular time intervals under a fluorescent microscope.
GFP live cell images were taken at indicated time-points
using same exposure condition within the group of com-
parison. For luciferase reporter assay, all data are pre-
sented as mean ± S.D. (n = 3), unless stated otherwise.
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